More recently, a dendrimer nano-radio-vehicle, containing lutetium-177 and encapsulated KRAS membrane association blocking molecule C19, was developed for a dual-targeted radio and chemotherapy in CXCR4+ pancreatic cancer cells [232]. The gene discussed is CXCR4; the disease is pancreatic neoplasm.